Physician profile
Thomas Lewis
NPI 1437716842
$614.23
in general payments reported to CMS, 2019-2025
10 companies · $45.03 in 2025
The $45.03 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.78 · 2022: $83.89 · 2023: $278 · 2024: $185 · 2025: $45.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $135.94 | 2023-2024 | Zynrelef |
| La Jolla Pharmaceutical Company | $94.50 | 2023 | Xerava |
| Conmed Corporation | $83.89 | 2022 | |
| Merck Sharp & Dohme LLC | $70.70 | 2023 | Lynparza |
| Medtronic, INC. | $47.80 | 2023 | Parietene Ds, Progrip |
| Ets Wound Care LLC | $45.03 | 2025 | Mirragen Advanced Wound Matrix |
| Cardiva Medical, INC. | $44.28 | 2023 | Cardiva Vascade 6/7f Vcs |
| Solventum Corporation | $37.43 | 2024 | V.A.C. Veraflo Cleanse Choice |
| Baxter Healthcare | $32.88 | 2024 | Perclot |
| Allergan, INC. | $21.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.